SEC Form 4 · accession 0001179110-15-010190
YIELD10 BIOSCIENCE, INC. · YTEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Shaulson
Officer — President & CEO · Director
Period of report
Jun 19, 2015
Accepted (ET)
Jun 23, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001121702
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 19, 2015 | P | 35,000 | $3.32 | A | 76,666 | D | |
| Common StockF2,F4 | holding | — | — | — | 100,000 | D | ||
| Common StockF2,F5 | holding | — | — | — | 137,566 | D | ||
| Common StockF2,F6 | holding | — | — | — | 201,667 | D | ||
| Common StockF2,F3 | holding | — | — | — | 5,233 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrants (right to buy)F1 | $3.98 | Jun 19, 2015 | P | 31,500 | A | Jun 19, 2015 | Jun 19, 2019 | Common Stock | 31,500 | 31,500 | D |
Explanation of responses
- F1The reported securities are included in 35,000 units of Issuer securities (the "Units") purchased by the reporting person for $3.4325 per Unit pursuant to a Securities Purchase Agreement, dated June 15, 2015 by and among the Issuer, the reporting person and certain other qualified institutional and individual investors. Each Unit consists of one share of the Issuer's Common Stock, par value $0.01 per share ("Common Stock") and and nine-tenths of a Common Stock warrant to purchase one share of Common Stock at an exercise price of $3.98 per share (subject to adjustment in the event of stock splits, stock dividends, reclassifications and the like).
- F2The shares of Common Stock reported herein give effect to the 1-for-6 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware on May 26, 2015.
- F3Shares acquired as Company matching contributions under the Metabolix, Inc. 401(k) Plan.
- F4These securities are in the form of restricted stock units ("RSUs"). Vesting of the RSUs is triggered, if at all, by the achievement of certain stock price or revenue based targets as set forth in the reporting person's employment agreement. If performance targets are met, the RSUs vest in various percentages on the first, second and third anniversaries, respectively, of the date such targets are achieved. To the extent vesting of the RSU's has not been triggered prior to 1/2/16, the RSUs will be forfeited and shall not vest under any circumstances.
- F5The securities are in the form of RSUs issued pursuant to the Issuer's 2014 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in their entirety on April 1, 2016. Except as provided in the reporting person's employment agreement, all RSUs that have not vested will automatically terminate upon the reporting person's termination of employment with the Issuer and its subsidiaries. Vesting of the RSUs is also subject to certain acceleration, continuation and termination provisions set forth in the reporting person's employment agreement.
- F6The securities are in the form of RSUs issued pursuant to the Issuer's 2014 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in four (4) equal annual installments beginning on April 1, 2016. Except as otherwise provided in the reporting person's employment agreement, all RSUs that have not vested will automatically terminate upon the reporting person's termination of employment with the Issuer and its subsidiaries. Vesting of the RSUs is also subject to certain acceleration, continuation and termination provisions set forth in the reporting person's employment agreement.